BP366

Gliclazide impurity F

British Pharmacopoeia (BP) Reference Standard

• Synonim(y): N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-2-methylbenzenesulfonamide, 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl)sulphonyl]urea
• Wzór empiryczny (zapis Hilla): C₁₅H₂₁N₃O₃S
• Numer CAS: 1076198-18-9
• Masa cząsteczkowa: 323.41
• MDL number: MFCD08063770
• UNSPSC Code: 41116107
• NACRES: NA.24

Właściwości

• grade: pharmaceutical primary standard
• agency: BP
• API family: gliclazide
• form: solid
• shelf life: limited shelf life, expiry date on the label
• manufacturer/tradename: BP
• application(s): pharmaceutical; pharmaceutical small molecule
• format: neat
• storage temp.: 2-8°C
• SMILES string: [S](=O)(=O)(NC(=O)NN2CC3C(C2)CCC3)c1c(cccc1)C
• InChI: 1S/C15H21N3O3S/c1-11-5-2-3-8-14(11)22(20,21)17-15(19)16-18-9-12-6-4-7-13(12)10-18/h2-3,5,8,12-13H,4,6-7,9-10H2,1H3,(H2,16,17,19)
• InChI key: XLSAYFQNZDWDHT-UHFFFAOYSA-N

Opis

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Gliclazide impurity F BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Gliclazide Tablets

Packaging

Unit quantity: 30 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Other Notes

Sales restrictions may apply.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable